🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Pathological Response After Neoadjuvant Treatment on NSCLC

Recruitingn/aAges 18 Years - anyAllFundación GECP
NCT05167487 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This is a non-interventional, observational, multicenter and retrospective study. Being limited to the collection of patient data already filled in the Tumor Thoracic Registry data base and the data from stage IIIA clinical trials case report forms.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patients with resectable stage IIIA disease (according to American Joint Committee on Cancer \[AJCC\] lung cancer edition 7 or 8) who were included in the Tumor Thoracic Registry data base and in stage IIIA clinical trials which the sponsor is Fundación GECP. * Patients with histologically N2 involvement confirmed * Patients diagnosed as stage IIIA from 2010 and 2017 * Patients who have received neoadjuvant platinum-based treatment and surgery * Age ≥ 18 years at time of study entry * PET /TC at diagnosis Exclusion Criteria: * Patients who received chemoradiotherapy neoadjuvant treatment * Patients who were not resected after neoadjuvant treatment * Patients who were diagnosed after June 2017
💊

What it tests

  • Cisplatin
  • Carboplatin
📍

Where

17 sites
Hospital Universitario De A Coruna
A Coruña, Spain
Hospital General Universitario de Alicante
Alicante, Spain
ICO Badalona, Hospital Germans Trias i Pujol
Badalona, Spain
Hospital Vall d'Hebron
Barcelona, Spain
Hospital de la Santa Creu i Sant Pau
Barcelona, Spain
ICO Hospitalet
L'Hospitalet de Llobregat, Spain
Hospital Universitario Insular de Gran canaria
Las Palmas de Gran Canaria, Spain
Hospital Dr. Negrín
Las Palmas de Gran Canaria, Spain

…and 9 more on ClinicalTrials.gov.

🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy